Rheumatology
Conference Coverage
Obinutuzumab promotes renal preservation in lupus nephritis
A post hoc analysis of the NOBILITY trial showed improved outcomes for patients taking obinutuzumab (Gazyva), compared with placebo.
From the Journals
Short steroid taper tested with tocilizumab for giant cell arteritis
Results from a pilot study examining a shortened prednisone taper of 8 weeks’ length rather than 26 weeks suggest it may be possible to reduce...
Conference Coverage
CPPD nomenclature is sore subject for gout group
G-CAN hopes to standardize terminology and finally oust ‘pseudo’ vernacular.
Conference Coverage
Gout: Studies support early use of urate-lowering therapy, warn of peripheral arterial disease
Urate-lowering drugs might be OK early on; gout may boost peripheral arterial disease.
Latest News
Review estimates acne risk with JAK inhibitor therapy
Acne has been reported to be an adverse effect of JAK inhibitors, but not much is known about how common acne is overall.
Conference Coverage
Researchers tease apart multiple biologic failure in psoriasis, PsA
Patients failing two or more biologic agents of different mechanistic classes “are really suffering. We need to have better guidelines and...
Latest News
AI app can do biomechanical analysis in minutes
The motion-capture app could help clinicians design better interventions to ward off mobility problems and speed recovery.
News from the FDA/CDC
FDA OKs first ustekinumab biosimilar
The drug has also been granted an interchangeability designation and has been approved for six indications.
News from the FDA/CDC
FDA approves abatacept for pediatric patients with psoriatic arthritis
As many as 5% of pediatric patients with juvenile idiopathic arthritis are estimated to have juvenile PsA.
From the Journals
RA precision medicine using synovial biopsy ‘remains elusive’
Histologic analysis did not sufficiently predict treatment response to certain medications, but gene expression and transcriptome analysis methods...
From the Journals
Positive trial of methotrexate in hand OA has modest results
A randomized controlled trial of methotrexate in inflammatory hand OA demonstrated clinical benefit, suggesting a potential role for...